(Q46471752)

English

Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats

scientific article published in November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15870833

Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15870833

0 references

Marcello Solinas

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15870833

Gianluigi Tanda

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15870833

Alexandros Makriyannis

4

object named as

Alexandros Makriyannis

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

author name string

Leigh V Panlilio

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15870833

Stephanie A Matthews

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15870833

Steven R Goldberg

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15870833

language of work or name

0 references

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15870833

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15870833

30

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15870833

11

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15870833

2046-2057

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15870833

Transition from moderate to excessive drug intake: change in hedonic set point.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Cannabinoid receptor and WIN 55 212‐2‐stimulated [35S]‐GTPγS binding in the brain of mu‐, delta‐ and kappa‐opioid receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

The enzymatic inactivation of the fatty acid amide class of signaling lipids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

The endocannabinoid system and its therapeutic exploitation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Anandamide: some like it hot.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Role of endogenous cannabinoids in synaptic signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Progressive ratio as a measure of reward strength.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

The cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Modulation of anxiety through blockade of anandamide hydrolysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Substance dependence as a compulsive behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Variability of drug self-administration in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

The molecular logic of endocannabinoid signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

The endogenous cannabinoid system and the treatment of marijuana dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Structural determinants for recognition and translocation by the anandamide transporter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Molecular mechanisms of opiate receptor coupling to G proteins and effector systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Heroin self-administration in rats under a progressive ratio schedule of reinforcement.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Exposure to delta-9-tetrahydrocannabinol (THC) increases subsequent heroin taking but not heroin's reinforcing efficacy: a self-administration study in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Cocaine self-administration "binges": transition from behavioral and autonomic regulation toward homeostatic dysregulation in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Satiety threshold: a quantitative model of maintained cocaine self-administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

The anandamide transport inhibitor AM404 activates vanilloid receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

21 January 2018

Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

7 January 2021

based on heuristic

inferred from DOI database lookup

Potentiation of anandamide hypotension by the transport inhibitor, AM404

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

7 January 2021

based on heuristic

inferred from DOI database lookup

Presynaptic Facilitation of Glutamatergic Synapses to Dopaminergic Neurons of the Rat Substantia Nigra by Endogenous Stimulation of Vanilloid Receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional interaction between opioid and cannabinoid receptors in drug self-administration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

7 January 2021

based on heuristic

inferred from DOI database lookup

Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

7 January 2021

based on heuristic

inferred from DOI database lookup

Activational role of cannabinoids on movement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

7 January 2021

based on heuristic

inferred from DOI database lookup

The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300754

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300754

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15870833

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15870833

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46471752&oldid=2207888949"